Franklin Resources
IMNM icon

Franklin Resources’s Immunome IMNM Stock Holding History

Franklin Resources’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
58,998
+22,976
+64% +$492K ﹤0.01% 2188
2026
Q1 		$788K Buy
+36,022
New +$802K ﹤0.01% 2281

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Franklin Resources's IMNM Position: Q2 2026 in Review

Franklin Resources increased its Immunome (IMNM) stake by 64% in Q2 2026, buying an estimated $492K and bringing the position to 58,998 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2188.

Franklin Resources first reported a position in IMNM in Q1 2026 and has held it in 2 quarters since. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Franklin Resources held 58,998 shares of Immunome worth $1.25M as of Q2 2026.
  • Franklin Resources bought 22,976 Immunome shares in Q2 2026, an estimated $492K.
  • Immunome made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2188 holding.
  • Franklin Resources first reported a position in Immunome in Q1 2026 and has held it in 2 quarters since.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.